Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Thyroid Cancer: Imaging and Therapy Update

  • Pediatrics (L Averill, Section Editor)
  • Published:
Current Radiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

In 2015, the management of thyroid cancer in the pediatric population was overhauled with the publication of the inaugural American Thyroid Association guidelines for children with thyroid nodules and differentiated thyroid cancer. In this article, we review these guidelines along with recent relevant literature regarding pediatric thyroid cancer, focusing on salient issues relating to imaging and radionuclide therapy.

Recent Findings

The American College of Radiology recently published its inaugural recommendations for thyroid nodule imaging (TI-RADS). Regarding radionuclide therapy, recent literature has focused on ways to reduce long-term sequelae while providing optimal initial treatment.

Summary

While a more standardized approach is being taken towards initial imaging of thyroid nodules and cancer, the opposite approach to treatment and surveillance is developing, with a focus on personalization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Dermody S, Walls A, Harley EH Jr. Pediatric thyroid cancer: an update from the SEER database 2007-2012. Int J Pediatr Otorhinolaryngol. 2016;89:121–6. doi:10.1016/j.ijporl.2016.08.005.

    Article  PubMed  Google Scholar 

  2. • Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 2015;25:716–59. doi:10.1089/thy.2014.0460. The inaugural ATA Guidelines for management of pediatric thyroid cancer.

  3. Rivkees SA, Dinauer CA. The pediatric thyroid nodule and papillary thyroid cancer management. In: Roman SA, Sosa JA, Solorzano CC, editors. Management of thyroid nodules and differentiated thyroid cancer. Cham: Springer; 2017.

    Google Scholar 

  4. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192–202. doi:10.1007/s00268-009-0364-0.

    Article  PubMed  Google Scholar 

  5. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, et al. American Thyroid Association guidelines on the management of thyroid nodules and differentiated Thyroid Cancer Task Force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27:481–3. doi:10.1089/thy.2016.0628.

    Article  CAS  PubMed  Google Scholar 

  6. Kloos RT. Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab. 2010;95:5241–8. doi:10.1210/jc.2010-1500.

    Article  CAS  PubMed  Google Scholar 

  7. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93:504–15.

    Article  CAS  PubMed  Google Scholar 

  8. Brown VJ. Thyroid cancer after Chornobyl: increased risk persists two decades after radioiodine exposure. Environ Health Perspect. 2011;119:A306. doi:10.1289/ehp.119-a306a.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer. 2011;117:4439–46. doi:10.1002/cncr.26070.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yeh MW, Bauer AJ, Bernet VA, Ferris RL, Loevner LA, Mandel SJ, et al. American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid. 2015;25:3–14. doi:10.1089/thy.2014.0096.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Koltin D, O’Gorman CS, Murphy A, Ngan B, Daneman A, Navarro OM, et al. Pediatric thyroid nodules: ultrasonographic characteristics and inter-observer variability in prediction of malignancy. J Pediatr Endocrinol Metab. 2016;29:789–94. doi:10.1515/jpem-2015-0242.

    Article  PubMed  Google Scholar 

  12. Lim-Dunham JE, Erdem Toslak I, Alsabban K, Aziz A, Martin B, Okur G, et al. Ultrasound risk stratification for malignancy using the 2015 American Thyroid Association management guidelines for children with thyroid nodules and differentiated thyroid cancer. Pediatr Radiol. 2017;47:429–36. doi:10.1007/s00247-017-3780-6.

    Article  PubMed  Google Scholar 

  13. Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR Thyroid Imaging, Reporting and Data System (TIRADS) Committee. J Am Coll Radiol. 2015;12:1272–9. doi:10.1016/j.jacr.2015.07.011.

    Article  PubMed  Google Scholar 

  14. • Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14:587–95. doi:10.1016/j.jacr.2017.01.046. TI-RADS is a new system that is being implemented to standardize reporting of thyroid nodules across different providers and institutions.

  15. McHenry CR, Huh ES, Machekano RN. Is nodule size an independent predictor of thyroid malignancy? Surgery. 2008;144:1062–9. doi:10.1016/j.surg.2008.07.021.

    Article  PubMed  Google Scholar 

  16. Drozd VM, Lushchik ML, Polyanskaya ON, Fridman MV, Demidchik YE, Lyshchik AP, et al. The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident. Thyroid. 2009;19:725–34. doi:10.1089/thy.2008.0238.

    Article  PubMed  Google Scholar 

  17. Lyshchik A, Drozd V, Demidchik Y, Reiners C. Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US. Radiology. 2005;235:604–13.

    Article  PubMed  Google Scholar 

  18. Moon HJ, Kwak JY, Kim MJ, Son EJ, Kim EK. Can vascularity at power Doppler US help predict thyroid malignancy? Radiology. 2010;255:260–9. doi:10.1148/radiol.09091284.

    Article  PubMed  Google Scholar 

  19. Yoon JH, Shin HJ, Kim EK, Moon HJ, Roh YH, Kwak JY. Quantitative evaluation of vascularity using 2-D power Doppler ultrasonography may not identify malignancy of the thyroid. Ultrasound Med Biol. 2015;41:2873–83. doi:10.1016/j.ultrasmedbio.2015.07.009.

    Article  PubMed  Google Scholar 

  20. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92:3590–4.

    Article  CAS  PubMed  Google Scholar 

  21. Ruhlmann M, Jentzen W, Ruhlmann V, Pettinato C, Rossi G, Binse I, et al. High level of agreement between pretherapeutic 124I PET and intratherapeutic 131I imaging in detecting iodine-positive thyroid cancer metastases. J Nucl Med. 2016;57:1339–42. doi:10.2967/jnumed.115.169649.

    Article  PubMed  Google Scholar 

  22. Kist JW, de Keizer B, van der Vlies M, Brouwers AH, Huysmans DA, van der Zant FM, et al. 124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer: results of a multicenter diagnostic cohort study (THYROPET). J Nucl Med. 2016;57:701–7. doi:10.2967/jnumed.115.168138.

    Article  PubMed  Google Scholar 

  23. Niedziela M, Breborowicz D, Trejster E, Korman E. Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. J Pediatr Endocrinol Metab. 2002;15:823–30.

    Article  CAS  PubMed  Google Scholar 

  24. • Parisi MT, Eslamy H, Mankoff D. Management of differentiated thyroid cancer in children: focus on the American Thyroid Association pediatric guidelines. Semin Nucl Med. 2016;46:147–64. doi:10.1053/j.semnuclmed.2015.10.006. This is an excellent review of radionuclide therapy and management of pediatric thyroid cancer, which also discusses the inaugural ATA guidelines.

  25. Azmat U, Porter K, Senter L, Ringel MD, Nabhan F. Thyroglobulin liquid chromatography-tandem mass spectrometry has a low sensitivity for detecting structural disease in patients with antithyroglobulin antibodies. Thyroid. 2017;27:74–80. doi:10.1089/thy.2016.0210.

    Article  CAS  PubMed  Google Scholar 

  26. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med. 2005;46:261–6.

    PubMed  Google Scholar 

  27. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer. 2003;89:1638–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf). 1998;49:619–28.

    Article  CAS  Google Scholar 

  29. Bargren AE, Meyer-Rochow GY, Delbridge LW, Sidhu SB, Chen H. Outcomes of surgically managed pediatric thyroid cancer. J Surg Res. 2009;156:70–3. doi:10.1016/j.jss.2009.03.088.

    Article  PubMed  Google Scholar 

  30. Luster M, Pfestroff A, Hänscheid H, Verburg FA. Radioiodine therapy. Semin Nucl Med. 2017;47:126–34. doi:10.1053/j.semnuclmed.2016.10.002.

    Article  PubMed  Google Scholar 

  31. Verburg FA, Mader U, Luster M, Hänscheid H, Reiners C. Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2015;42:1390–8. doi:10.1007/s00259-015-3076-8.

    Article  CAS  PubMed  Google Scholar 

  32. Biko J, Reiners C, Kreissl MC, Verburg FA, Demidchik Y, Drozd V. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur J Nucl Med Mol Imaging. 2011;38:651–5. doi:10.1007/s00259-010-1669-9.

    Article  PubMed  Google Scholar 

  33. Van Nostrand D, Atkins F, Yeganeh F, Acio E, Bursaw R, Wartofsky L. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid. 2002;12:121–34.

    Article  PubMed  Google Scholar 

  34. Lassmann M, Reiners C, Luster M. Dosimetry and thyroid cancer: the individual dosage of radioiodine. Endocr Relat Cancer. 2010;17:R161–72. doi:10.1677/ERC-10-0071.

    Article  CAS  PubMed  Google Scholar 

  35. Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med. 1983;309:937–41.

    Article  CAS  PubMed  Google Scholar 

  36. Chiesa C, Castellani MR, Vellani C, Orunesu E, Negri A, Azzeroni R, et al. Individualized dosimetry in the management of metastatic differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2009;53:546–61.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Mount Sinai St. Luke’s & Mount Sinai West, 1000 10th Avenue, New York, NY, 10019, USA

    Nii Koney & Soran Mahmood

  2. Department of Endocrinology, Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE, 19803, USA

    Anthony Gannon

  3. Department of Radiology, Nemours/Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE, 19803, USA

    Mark S. Finkelstein & Tejal Mody

Authors
  1. Nii Koney
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soran Mahmood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anthony Gannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark S. Finkelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tejal Mody
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tejal Mody.

Ethics declarations

Conflict of Interest

Nii Koney, Soran Mahmood, Anthony Gannon, Mark S. Finkelstein, and Tejal Mody each declare no potential conflicts of interest.

Human and Animal Rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical collection on Pediatrics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koney, N., Mahmood, S., Gannon, A. et al. Pediatric Thyroid Cancer: Imaging and Therapy Update. Curr Radiol Rep 5, 48 (2017). https://doi.org/10.1007/s40134-017-0247-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40134-017-0247-3

Keywords

Search

Navigation